tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jim Birchenough, 105 are a BUY (65.22%), 3 are a SELL (1.86%), 53 are a HOLD (32.92%).
Analyst Jim Birchenough, currently employed at WELLS FARGO, carries an average stock price target met ratio of 66.95% that have a potential upside of 38.03% achieved within 360 days.
Jim Birchenough’s has documented 346 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SGMO, Sangamo Therapeutics at 02-Jan-2025.
Analyst best performing recommendations are on INFI (INFINITY PHARMACEUTICALS).
The best stock recommendation documented was for BLCM (BELLICUM PHARMACEUTICALS) at 2/14/2020. The price target of $4 was fulfilled within 31 days with a profit of $6.42 (61.61%) receiving and performance score of 19.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$30
5 years 1 months 5 days ago
(01-Sep-2020)
2/8 (25%)
$14.76 (96.85%)
30
Hold
$20
$1.83 (10.07%)
$31
5 years 5 months ago
(06-May-2020)
1/2 (50%)
$4.76 (31.23%)
9
Buy
$24
5 years 11 months 29 days ago
(07-Oct-2019)
4/5 (80%)
$5.96 (33.04%)
37
Hold
7 years 11 days ago
(25-Sep-2018)
2/2 (100%)
$1.2 (5.04%)
27
What Year was the first public recommendation made by Jim Birchenough?
